Figure 1
From: IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
IL-6 levels in esophageal SCC. a. Representative IHC staining with an anti-IL-6 antibody of esophageal cancer and adjacent non-malignant epithelium from TMA blocks. b. IHC staining with an anti-IL-6 antibody of human esophageal cancer specimens. Images of representative slides are shown at magnifications of × 100 (left panel) and × 200 (right panel). c. Representative images of IHC staining with an anti-IL-6R antibody of esophageal cancer and adjacent non-malignant epithelium from TMA blocks.